ICU Medical shares are trading lower after the company reported Q2 EPS $1.99 Misses $2.06 Estimate, Sales $312.282M Beat $309.13M Estimate.﻿ Raymond James downgraded the stock from Strong Buy to Outperform.
Benzinga Newsdesk